By clicking on “Accept all cookies”, you agree that cookies may be stored on your device in order to improve site navigation, analyze site usage, and help us with our marketing efforts.
PreferencesRefuseAccept everything
Privacy Preference Center
When you visit websites, they can store or retrieve data in your browser. This storage is often required for the basic functionality of the website. It can be used for marketing, analysis, and site personalization purposes, for example to save your preferences. Privacy is important to us, which is why you have the option of deactivating certain types of storage that are not necessary for the basic functioning of the website. Blocking certain categories may impact your website experience.
Refuse everythingAccept everything
Manage consent preferences by category
Essential
Always active
These elements are necessary to allow the basic functioning of the website.
Marketing
These elements are used to deliver ads that are more relevant to you and your interests. They can also be used to limit the number of times you see an ad and measure the effectiveness of ad campaigns. Advertising networks usually place them with the permission of the website operator.
Personalization
These elements allow the website to remember the choices you make (such as your username, language, or the region in which you are located) and to provide improved and more personal functions. For example, a website can provide you with local weather reports or traffic information by storing data about your current location.
Analytics
These elements help the website operator understand how their site works, how visitors interact with the site, and whether there are technical issues. This type of storage does not generally collect information that can identify a visitor.
Confirm my preferences and close
ThesisOur thesisNewspaperInvestorsEntrepreneurs
Valorous Circle
InvestorsEntrepreneurs
ENG
FRA
ENG

News

icon plus blue and orange valeureux

Paris Sept. 23

23/9/2024
Philippe NUSSBAUMER
General Partner

Plus d'informations à venir

icon plus blue and orange valeureux

News

France Parkinson invests in SAPPIENS

11/3/2025
Find the press release.
More information on this news →

Brussels October 4, 2024

4/10/2024
We will be in Brussels to support CXS Therapeutics during its meetings with a foundation that works on rare diseases. Let's meet on the occasion of this trip.
More information on this news →

Paris Sept. 23

23/9/2024
One to One meeting with investors/LP - get in touch, we still have a few slots left
More information on this news →

Lium - levee

20/8/2024
The capital increase was completed in the middle of August. Welcome Thomas and Guilain, PR to follow.
More information on this news →
icon plus blue and orange valeureux

More items

Letter 4 CXS Therapeutics SAPPIENS

2nd successful fundraiser for CXS Therapeutics - on the way to the clinic!
Read the article

letter1-the-story-of-cxs-therapeutics--1er-episode

letter1-the-story-of-cxs-therapeutics--1er-episode
Read the article

Letter 3 CXS Therapeutics Sappiens

Here is the third and final episode of this first series of letters dedicated to Sappiens from CXS Therapeutics, the company that invented the first neuroprotective treatment for Parkinson's disease.
Read the article

CXS Therapeutics Letter 2

Letter 2 CXS Therapeutics - It tells the story of the meeting and the first steps of CXS Therapeutics and the Valeureux fund.
Read the article
Early DeepTech?InvestorsEntrepreneursAbout
The letter
Thank you for subscribing to the newsletter
Whoops! An error occurred during registration
Investing in good conscience at the right time.
Make an appointment

Valeureux is a management company registered with the AMF under the number EN-24000009

Legal informationConfidentiality policy